Medications
Cancer drug may be lifesaver for hospitalized COVID patients
An experimental drug used to fight cancer may reduce the risk of death for COVID-19 patients by roughly 55%, a new study suggests.
Jul 6, 2022
0
11
NEJM Evidence
Health
Kidney patients benefit from physical exercises, finds study of 21 dialysis centers
Patients who engage in light exercise while undergoing dialysis are physically fitter and are admitted to hospital less frequently than those who do not. These are the findings of a large-scale study conducted by a consortium ...
Jul 14, 2023
1
55
Oncology & Cancer
New optimism on myelodysplastic syndromes
Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review in the Journal of the American Medical Association that clarifies current treatment ...
Nov 2, 2022
0
58
Oncology & Cancer
New clinical tool for clonal hematopoiesis identifies patients at high risk for blood cancer
A new clinical tool developed by a team of researchers led by the Dana-Farber Cancer Institute pinpoints which Clonal hematopoiesis patients are at highest risk for cancer progression. Their work was published this week in ...
Apr 26, 2023
0
2
Medications
Forxiga trial shows clinically meaningful improvements in glycemic control among patients aged 10–17 years
Positive results from the T2NOW Phase III trial demonstrated significant reduction in A1C, a marker of average blood sugar, for patients treated with Forxiga (dapagliflozin) compared with patients receiving placebo. Adjusted ...
Oct 11, 2023
0
20
Medications
Global trial confirms benefit of antacids on bleeding prevention for ventilated patients
A widely available drug helps prevent upper gastrointestinal bleeding in critically ill adults on a breathing machine, according to the results of a global study and meta-analysis led by researchers at McMaster University.
Jun 14, 2024
0
16
Medical research
Researchers identify biomarkers that predict preeclampsia risk
In a study of pregnant women in the United States, Cedars-Sinai investigators found that a specific imbalance of two placental proteins could predict which women were at risk of developing a severe form of preeclampsia, a ...
Nov 9, 2022
0
15
Health
Research shows lasting effects of smoking after quitting
Researchers are still discovering how smoking continues to harm people's health even years after they quit, with a new study on Wednesday revealing tobacco's lasting effect on the immune system.
Feb 18, 2024
0
4
Immunology
Study finds feeding infants peanut products protects against allergy into adolescence
Feeding children peanuts regularly from infancy to age five reduced the rate of peanut allergy in adolescence by 71%, even after many years when the children ate or avoided peanut as desired.
May 27, 2024
0
288
Medications
Tezepelumab reduces mucus plugs in adults with uncontrolled asthma
Tezepelumab is associated with a reduction in occlusive mucus plugs versus placebo in adults with uncontrolled asthma, according to a study published in the October issue of NEJM Evidence.
Sep 29, 2023
0
1
